Why is Lupin Ltd. ?
- PBT LESS OI(Q) At Rs 1,916.97 cr has Grown at 82.3% (vs previous 4Q average)
- ROCE(HY) Highest at 22.22%
- OPERATING PROFIT TO INTEREST(Q) Highest at 21.76 times
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -1.15%, its profits have risen by 64.7% ; the PEG ratio of the company is 0.3
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to Lupin should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Lupin for you?
Medium Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 1,916.97 cr has Grown at 82.3% (vs previous 4Q average
Highest at 22.22%
Highest at 21.76 times
Highest at Rs 7,047.51 cr
Highest at Rs 2,341.33 cr.
Highest at 33.22%
Highest at Rs 1,477.92 cr.
Highest at Rs 32.35
Highest at 0.32 times
Lowest at 3.84 times
Highest at Rs 107.59 cr
Here's what is working for Lupin
PBT less Other Income (Rs Cr)
Operating Profit to Interest
PAT (Rs Cr)
Net Sales (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
EPS (Rs)
Here's what is not working for Lupin
Interest Paid (Rs cr)
Debt-Equity Ratio
Debtors Turnover Ratio
Non Operating Income






